What is the recommended dose of Keflex (cephalexin) for pediatric patients with open fractures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Cephalexin Dosing for Open Fractures

For pediatric open fractures, cephalexin is NOT the appropriate antibiotic choice—cefazolin is the preferred agent for prophylaxis and should be administered intravenously at 33 mg/kg/dose every 8 hours. 1

Why Cephalexin is Inappropriate for Open Fractures

Cephalexin is an oral first-generation cephalosporin that lacks the pharmacokinetic properties needed for acute open fracture management, which requires immediate intravenous antibiotic administration. 1, 2

Critical Distinctions Between Cephalexin and Cefazolin

  • Route of administration: Cephalexin is oral only and requires absorption from the upper intestine, delaying therapeutic levels 3. Open fractures demand immediate IV antibiotics, ideally within 1 hour of injury 1

  • Tissue penetration: While cephalexin provides adequate coverage for skin and soft tissue infections at 25-50 mg/kg/day divided doses 2, open fractures require the superior bone penetration and immediate high serum levels achieved with IV cefazolin 1

  • Clinical evidence: Studies specifically examining open fracture management utilize cefazolin or ceftriaxone, not cephalexin 4. The IDSA recommends cefazolin as the preferred agent for open fracture prophylaxis 1

Correct Antibiotic Management for Pediatric Open Fractures

Cefazolin 33 mg/kg/dose IV every 8 hours is the evidence-based recommendation, with the first dose administered as soon as possible after injury. 1

Dosing Parameters

  • Maximum daily dose: 150 mg/kg/day divided into three doses (every 8 hours), with no absolute maximum in milligrams 1

  • Duration: Short-course therapy is appropriate; antibiotics should not extend beyond 24-48 hours post-closure for uncomplicated open fractures 1

  • Fracture grade considerations: For mild to moderate open fractures (Gustilo-Anderson grades 1-2), cefazolin monotherapy is appropriate 1. Grade 3 fractures may require broader coverage 4

Alternative IV Cephalosporin Option

Ceftriaxone offers equivalent efficacy with the advantage of once-daily dosing (24-hour intervals) and single-agent coverage for grade 3 open fractures. 4 This provides resource efficiency without increasing infectious complications 4

When Cephalexin Might Be Considered

Cephalexin could only be appropriate as oral step-down therapy after initial IV antibiotics and surgical debridement, NOT as initial management. 2, 5

  • For Seymour fractures (distal phalanx juxta-epiphyseal fractures in children), cephalexin has been used successfully after emergency department management at standard pediatric dosing of 25-50 mg/kg/day divided every 6-12 hours 2, 5

  • This represents a specific clinical scenario where the fracture has been reduced and the wound managed, allowing transition to oral antibiotics 5

Common Pitfalls to Avoid

  • Never use oral antibiotics as initial therapy for open fractures—this delays adequate tissue levels and increases infection risk 1

  • Do not confuse cephalexin (oral) with cefazolin (IV)—they are different drugs despite both being first-generation cephalosporins 1, 2

  • Avoid extending antibiotic prophylaxis beyond 24-48 hours post-closure unless there are specific indications, as this does not improve outcomes and promotes resistance 1

References

Guideline

Cefazolin Dosing for Open Finger Fractures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Research

Treatment of Acute Seymour Fractures.

Journal of pediatric orthopedics, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.